Ovarian Epithelial Tumor (OV)
Overview
OV is the OncoTree umbrella code for epithelial tumors of the ovary and fallopian tube. The dominant clinical subtype is high-grade serous ovarian cancer (HGSOC), which originates from the fallopian tube fimbria and is characterized by near-universal TP53 mutation, frequent homologous-recombination deficiency, and chromosomal instability.
Cohorts in the corpus
- ovary_geomx_gray_foundation_2024 — fallopian tube spatial-transcriptomics atlas across STIC.I → STIC.C → invasive HGSOC progression stages. PMID:39386723
Recurrent alterations
- TP53, BRCA1, BRCA2, CCNE1 — see HGSOC for the canonical subtype profile.
- Pan-cancer fusion study (9,624 TCGA samples) included OV as one of 33 TCGA cancer types; ovarian tumors were included in the gynecological cluster analyzed for arm-level aneuploidy; druggable fusions covered 6% of pan-can samples PMID:29617662
Subtypes
- HGSOC — high-grade serous (the dominant subtype; tracked as a separate page).
- Low-grade serous, endometrioid, clear-cell, and mucinous subtypes are clinically distinct but not directly profiled in the current corpus.
Therapeutic landscape
- Platinum-based chemotherapy (carboplatin, cisplatin) and PARP inhibitors (olaparib, rucaparib, veliparib) for HRD tumors. monalizumab is highlighted as a hypothetical interception target in PMID:39386723.
Sources
- PMID:39386723 — HGSOC precursor-to-cancer spatial atlas (Gray Foundation / GeoMx).
Page last touched by entity-page-writer on 2026-05-01.
This page was processed by crosslinker on 2026-05-04. - PMID:29617662
This page was processed by wiki-cli on 2026-05-15.